Aortic calcification, arterial stiffness and bone mineral density in patients with COPD

Artery Research

Volumn 5, Issue 1, 2011, Pages 30-36

  Bolton, Charlotte E ^a,b   McEniery, Carmel M ^c   Raj, Vimal ^d   McDonnell, Barry J ^b,e   Dixon, Adrian K ^f   Munnery, Margaret ^b   Sabit, Ramsey ^g   Screaton, Nicholas ^d   Stone, Michael ^h   Wilkinson, Ian B ^c   Shale, Dennis J ^b   Cockcroft, John R ^b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d PAPWORTH HOSPITAL   (United Kingdom)

^e CARDIFF METROPOLITAN UNIVERSITY   (United Kingdom)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^g CARDIFF AND VALE UNIVERSITY HEALTH BOARD   (United Kingdom)

^h CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Aortic stiffness; Lung function; Osteoporosis; Pulse wave velocity

Indexed keywords

CALCIUM;

ABDOMINAL AORTA; AGED; ARTERIAL STIFFNESS; ARTERY RUPTURE; ARTICLE; BONE DENSITY; CALCIFICATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HEMODYNAMICS; HUMAN; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PULSE WAVE; QUANTITATIVE ANALYSIS; SCORING SYSTEM; THORACIC AORTA;

EID: 79951580450     PISSN: 18729312     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.artres.2011.01.001     Document Type: Article

References (41)

1. McGarvey L.P., John M., Anderson J.A., Zvarich M., Wise R.A. TORCH clinical endpoint committee. Ascertainment of cause-specific mortality in COPD: operations of the TORCH clinical endpoint committee. Thorax 2007, 62(5):411-415.
2. Sin D.D., Anthonisen N.R., Soriano J.B., Agusti A.G. Mortality in COPD: role of comorbidities. Eur Respir J 2006, 28(6):1245-1257.
3. Sin D.D., Wu L., Man S.F. The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest 2005, 127(6):1952-1959.
4. 1: a new risk factor for coronary heart disease mortality. Am J Respir Crit Care Med 1995, 151:390-398.
5. Laurent S., Cockcroft J., Van Bortel L., Boutouyrie P., Giannattasio C., Hayoz D., et al. European network for non-invasive investigation of large arteries. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006, 27(21):2588-2605.
6. Sabit R., Bolton C.E., Edwards P.H., Pettit R.J., Evans W.D., McEniery C.M., et al. Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007, 175:1259-1265.
7. McAllister D.A., Maclay J.D., Mills N.L., Mair G., Miller J., Anderson D., et al. Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007, 176(12):1208-1214.
8. McEniery C.M., McDonnell B., So A., Aitken S., Bolton C.E., Munnery M., et al. Aortic calcification is associated with aortic stiffness and isolated systolic hypertension in healthy individuals. Hypertension 2009, 53(3):524-531.
9. Aoki A., Kojima F., Uchida K., Tanaka Y., Nitta K. Associations between vascular calcification, arterial stiffness and bone mineral density in chronic hemodialysis patients. Geriatr Gerontol Int 2009, 9(3):246-252.
10. Frost M.L., Grella R., Millasseau S.C., Jiang B.Y., Hampson G., Fogelman I., et al. Relationship of calcification of atherosclerotic plaque and arterial stiffness to bone mineral density and osteoprotegerin in postmenopausal women referred for osteoporosis screening. Calcif Tissue Int 2008, 83(2):112-120.
11. Celli B.R., MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004, 23:932-946.
12. Cockcroft D.W., Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 1976, 16:31-41.
13. Bowden D.J., Aitken S.R., Wilkinson I.B., Dixon A.K. Interobserver variability in the measurement of abdominal aortic calcification using unenhanced CT. Br J Radiol 2009, 82(973):69-72.
14. Lomas D.A., Silverman E.K., Edwards L.D., Miller B.E., Coxson H.O., Tal-Singer R. Evaluation of COPD longitudinally to identify predictive surrogate endpoints (ECLIPSE) investigators. Evaluation of serum CC-16 as a biomarker for COPD in the ECLIPSE cohort. Thorax 2008, 63(12):1058-1063.
15. Bolton C.E., Ionescu A.A., Shiels K., Pettit R.J., Edwards P.H., Stone M.D., et al. Associated loss of fat free mass and bone mineral density in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004, 170:1286-1293.
16. Prevention and management of osteoporosis 1998, WHO, WHO, Technical Report Series 921.
17. Bolton C.E., Cockcroft J.R., Sabit R., Munnery M., McEniery C.M., Wilkinson I.B., et al. Lung function in mid-life compared with later life is a stronger predictor of arterial stiffness in men: the Caerphilly prospective study. Int J Epidemiol 2009, 38(3):867-876.
18. Cardoso C.R., Ferreira M.T., Leite N.C., Barros P.N., Conte P.H., Salles G.F. Microvascular degenerative complications are associated with increased aortic stiffness in type 2 diabetic patients. Atherosclerosis 2009, 205(2):472-476.
19. Pessina A.C. Target organs of individuals with diabetes caught between arterial stiffness and damage to the microcirculation. J Hypertens 2007, 25(Suppl. 1):S13-S18.
20. Sabit R., Bolton C.E., Fraser A.G., Edwards J.M., Edwards P.H., Ionescu A.A., et al. Sub-clinical left and right ventricular dysfunction in patients with COPD. Respir Med 2010, 104:1171-1178.
21. Abedin M., Tintut Y., Demer L.L. Vascular calcification: mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol 2004, 24(7):1161-1170.
22. Needham M., Stockley R.A. Alpha 1-antitrypsin deficiency. 3: clinical manifestations and natural history. Thorax 2004, 59(5):441-445.
23. Maclay J.D., McAllister D.A., Rabinovich R., Mathers M., Maxwell S., Weller R., et al. Systemic elastin degradation in COPD. Presented at ERS lung science conference 2010.
24. Niederhoffer N., Lartaud-Idjouadiene I., Giummelly P., Duvivier C., Peslin R., Atkinson J. Calcification of medial elastic fibers and aortic elasticity. Hypertension 1997, 29:999-1006.
25. Aikawa E., Aikawa M., Libby P., Figueiredo J.L., Rusanescu G., Iwamoto Y., et al. Arterial and aortic valve calcification abolished by elastolytic cathepsin S deficiency in chronic renal disease. Circulation 2009, 119(13):1785-1794.
26. Qin X., Corriere M.A., Matrisian L.M., Guzman R.J. Matrix metalloproteinase inhibition attenuates aortic calcification. Arterioscler Thromb Vasc Biol 2006, 26(7):1510-1516.
27. Pereira L., Lee S.Y., Gayraud B., Andrikopoulos K., Shapiro S.D., Bunton T., et al. Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-1. Proc Natl Acad Sci U S A 1999, 96(7):3819-3823.
28. Hjortnaes J., Butcher J., Figueiredo J.L., Riccio M., Kohler R.H., Kozloff K.M., et al. Arterial and aortic valve calcification inversely correlates with osteoporotic bone remodelling: a role for inflammation. Eur Heart J 2010, 31(16):1975-1984.
29. Dransfield M.T., Huang F., Nath H., Singh S.P., Bailey W.C., Washko G.R. CT emphysema predicts thoracic aortic calcification in smokers with and without COPD. COPD 2010, 7(6):404-410.
30. Maciewicz R.A., Warburton D., Rennard S.I. Can increased understanding of the role of lung development and aging drive new advances in chronic obstructive pulmonary disease?. Proc Am Thorac Soc 2009, 6(7):614-617.
31. Ito K., Barnes P.J. COPD as a disease of accelerated lung aging. Chest 2009, 135(1):173-180.
32. Hickson S.S., Butlin M., Graves M., Taviani V., Avolio A.P., McEniery C.M., et al. The relationship of age with regional aortic stiffness and diameter. JACC Cardiovasc Imaging 2010, 3(12):1247-1255.
33. Toussaint N.D., Lau K.K., Strauss B.J., Polkinghorne K.R., Kerr P.G. Relationship between vascular calcification, arterial stiffness and bone mineral density in a cross-sectional study of prevalent Australian haemodialysis patients. Nephrology (Carlton) 2009, 14(1):105-112.
34. Tankò L.B., Bagger Y.Z., Christiansen C. Low bone mineral density in the hip as a marker of advanced atherosclerosis in elderly women. Calcif Tissue Int 2003, 73(1):15-20.
35. Farhat G.N., Cauley J.A., Matthews K.A., Newman A.B., Johnston J., Mackey R., et al. Volumetric BMD and vascular calcification in middle-aged women: the study of women's health across the Nation. J Bone Miner Res 2006, 21(12):1839-1846.
36. Schulz E., Arfai K., Liu X., Sayre J., Gilsanz V. Aortic calcification and the risk of osteoporosis and fractures. J Clin Endocrinol Metab 2004, 89(9):4246-4253.
37. Dhore C.R., Cleutjens J.P., Lutgens E., Cleutjens K.B., Geusens P.P., Kitslaar P.J., et al. Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 2001, 21(12):1998-2003.
38. Hofbauer L.C., Schoppet M. Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases. J Am Med Assoc 2004, 292(4):490-495.
39. Price P.A., Faus S.A., Williamson M.K. Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption. Arterioscler Thromb Vasc Biol 2001, 21(5):817-824.
40. Bolton C.E., Schumacher W., Cockcroft J.R., Timpson N.J., Davey Smith G., Gallacher J., et al. The CRP genotype, serum levels and lung function in men: the Caerphilly prospective study. Clin Sci 2010, 12(8):347-355.
41. Coulson J.M., Rudd J.H.F., Duckers J.M., Rees J.I.S., Shale D.J., Bolton C.E., et al. Excessive aortic inflammation in chronic obstructive pulmonary disease - a FDG PET pilot study. J Nucl Med 2010, 51(9):1357-1360.